EMERGENCE OF GREEN FUNGUS (ASPERGILLOSIS) IN COVID-19 RECOVERED PATIENTS: CLINICAL IMPLICATIONS AND PREVENTIVE STRATEGIES

Authors

  • Senthil kumar.K.S
  • Senthilkumar G P
  • R Lavanya
  • Linisha.N.M
  • M. Sudha

Keywords:

COVID-19, Green Fungus, Aspergillosis, Opportunistic Infection, Immunocompromised

Abstract

The COVID-19 pandemic has led to increased vulnerability to secondary infections, including fungal diseases. Among

these, green fungus, caused by Aspergillus species, has recently emerged in India as a novel opportunistic infection in

COVID-19 recovered patients. A case in Madhya Pradesh involved a 34-year-old male, previously treated for severe

COVID-19, who developed green fungal infection in the lungs, sinuses, and bloodstream, accompanied by fever, nasal

bleeding, weight loss, and respiratory distress. While black (mucormycosis), white (Candida), and yellow fungal infections

have been previously reported, green fungus represents a new clinical challenge. This review summarizes current

knowledge on green fungal infections, including sources, transmission mechanisms, clinical manifestations, populations at

risk, and preventive measures, emphasizing the importance of early detection and proper management in

immunocompromised and post-COVID-19 patients.

Downloads

Published

2025-09-24

How to Cite

Senthil kumar.K.S, Senthilkumar G P, R Lavanya, Linisha.N.M, & M. Sudha. (2025). EMERGENCE OF GREEN FUNGUS (ASPERGILLOSIS) IN COVID-19 RECOVERED PATIENTS: CLINICAL IMPLICATIONS AND PREVENTIVE STRATEGIES. The Bioscan, 20(Special Issue-3), 987–991. Retrieved from https://thebioscan.com/index.php/pub/article/view/4140

Issue

Vol. 20 No. Special Issue-3 (2025): Volume 20 Special Issue 3 July (2025)

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.